Pharma Solvent Markets: DMF, Acetonitrile, and IPA as GLP-1 Production Ramps Up

Kuwait's Twice-Struck Desalination Plant Raises Questions About Regional Pharma Manufacturing Water Supply

Ceasefire Collapse Resets the Clock on Pharma Ingredient Supply Chain Recovery

The interim June 17 agreement to reopen Hormuz has collapsed

Specialty Chemical M&A: Celanese and Eastman H2 2026 Asset Sale Watch

Portfolio restructuring among major specialty chemical companies is creating new procurement considerations for buyers. As asset sales continue across the industry, companies should review supply agreements and strengthen supplier continuity planning for H2 2026.

China Chemical Watch: Gulf Competition Returns — Beijing's Industry Policy Response

China became the world's swing supplier during the Hormuz crisis, filling global supply gaps across commodity and specialty chemicals. As Gulf exports recover in H2 2026, Beijing is strengthening domestic chemical manufacturing while international buyers shift toward balanced multi-origin sourcing strategies.

GLP-1 API Scale-Up: Indian CDMO Capacity and the Pharmaceutical Chemical Inputs Race

India’s pharmaceutical CDMOs are racing to scale GLP-1 API production as semaglutide and tirzepatide patents expire in 2026. Buyers sourcing TFA, Fmoc amino acids, and peptide synthesis chemicals should prepare for significant supply tightening by Q4.

Glycerin (Pharma Grade): Oleochemical Supply Chain Disruptions Drive Price Pressure in 2026

Pharmaceutical-grade glycerin is experiencing sustained price pressure in 2026 as disruptions across the global oleochemical supply chain raise production costs. Pharmaceutical and personal care buyers are increasingly prioritizing supply security as the premium between pharma and technical-grade glycerin widens.